SCAI/AATS/ACC/STS operator and institutional requirements for transcatheter valve repair and replacement, Part III: Pulmonic valve

Catheterization and Cardiovascular Interventions

Volumn 86, Issue 1, 2015, Pages 85-93

  Hijazi, Ziyad M ^a   Ruiz, Carlos E ^b   Zahn, Evan ^c   Ringel, Richard ^d   Aldea, Gabriel S ^e   Bacha, Emile A ^f   Bavaria, Joseph ^g   Bolman, R Morton ^h   Cameron, Duke E ^d   Dean, Larry S ⁱ   Feldman, Ted ^j   Fullerton, David ^k   Horlick, Eric ^l   MacK, Michael J ^m   Miller, D Craig ⁿ   Moon, Marc R ^o   Mukherjee, Debabrata ^p   Trento, Alfredo ^c   Tommaso, Carl L ^q  

^a SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

^b LENOX HILL HEART AND VASCULAR INSTITUTE   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

^e UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^f Department of Medicine   (United States)

^g HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^j EVANSTON HOSPITAL   (United States)

^k UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY HEALTH NETWORK   (Canada)

^m Heart Hospital Baylor   (United States)

ⁿ STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^q NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; HEART CATHETERIZATION; HEART VALVE DISEASES; HEART VALVE REPLACEMENT; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; PULMONARY VALVE; STANDARDS; UNITED STATES;

AMERICAN HEART ASSOCIATION; CARDIAC CATHETERIZATION; CARDIOLOGY; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; PULMONARY VALVE; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84931840823     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25710     Document Type: Article

References (25)

1. Tommaso CL, Bolman III RM, Feldman T, et al., Multisociety (AATS, ACCF, SCAI, and STS) expert consensus statement: Operator and institutional requirements for transcatheter valve repair and replacement, Part 1: Transcatheter aortic valve replacement. J Am Coll Cardiol 2012; 59: 2028-2042.
2. Therrien J, Siu SC, McLaughlin PR, et al., Pulmonary valve replacement in adults late after repair of tetralogy of fallot: Are we operating too late? J Am Coll Cardiol 2000; 36: 1670-1675.
3. Aggarwal S, Garekar S, Forbes TJ, et al., Is stent placement effective for palliation of right ventricle to pulmonary artery conduit stenosis? J Am Coll Cardiol 2007; 49: 480-484.
4. Peng LF, McElhinney DB, Nugent AW, et al., Endovascular stenting of obstructed right ventricle-to-pulmonary artery conduits: A 15-year experience. Circulation 2006; 113: 2598-2605.
5. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM III, Thomas JD,. AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: e57-185.
6. Warnes CA, Williams RG, Bashore TM, et al., ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2008; 118: 2395-2451.
7. Ong K, Boone R, Gao M, et al., Right ventricle to pulmonary artery conduit reoperations in patients with tetralogy of fallot or pulmonary atresia associated with ventricular septal defect. Am J Cardiol 2013; 111: 1638-1643.
8. Batlivala SP, Emani S, Mayer JE, McElhinney DB,. Pulmonary valve replacement function in adolescents: A comparison of bioprosthetic valves and homograft conduits. Ann Thorac Surg 2012; 93: 2007-2016.
9. Miskovic A, Monsefi N, Doss M, et al., Comparison between homografts and Freestyle® bioprosthesis for right ventricular outflow tract replacement in Ross procedures. Eur J Cardiothorac Surg 2012; 42: 927-933.
10. Poynter JA, Eghtesady P, McCrindle BW, et al., Association of pulmonary conduit type and size with durability in infants and young children. Ann Thorac Surg. 2013; 96: 1695-1701.
11. Tweddell JS, Pelech AN, Frommelt PC, et al., Factors affecting longevity of homograft valves used in RVOT reconstruction for CHD. Circulation 2000; 102 (Suppl 3): III130-III135.
12. Homann M, Haehnel JC, Mendler N, et al., Reconstruction of the RVOT with valved biological conduits: 25 years experience with allografts and xenografts. Eur J Cardiothorac Surg 2000; 17: 624-630.
13. Oechslin E, Harrison DA, Harris I, et al., Reoperation in adults with repair of tetralogy of fallot: Indications and outcomes. J Thorac Cardiovasc Surg 1999; 118: 245-251.
14. Bonhoeffer P, Boudjemline Y, Saliba Z, et al., Transcatheter implantation of a bovine valve in pulmonary position. A lamb study. Circulation 2000; 102: 813-816.
15. Bonhoeffer P, Boudjemline Y, Saliba Z, et al., Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000; 356: 1403-1405.
16. Garay F, Webb J, Hijazi ZM,. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: First report in a human patient. Catheter Cardiovasc Interv 2006; 67: 659-662.
17. Khambadkone S, Coats L, Tahlor A, et al., Percutaneous pulmonary valve implantation in humans results in 59 consecutive patients. Circulation 2005; 112: 1189-1197.
18. Lurz P, Coats L, Khambadkone S, et al., Percutaneous pulmonary valve implantation impact of evolving technology and learning curve on clinical outcomes. Circulation 2008; 117: 1964-1972.
19. Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB,. Implantation of the Melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the U.S. Clinical trial. J Am Coll Cardiol 2009; 54: 1722-1729.
20. McElhinney DB, Hellenbrand WE, Zahn EM,. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US Melody valve trial. Circulation 2010; 122: 507-516.
21. Boone RH, Webb JG, Horlick E, Benson L, Cao QL, et al., Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve. Cathet Cardiovasc Interven 2010; 75: 286-294.
22. Kenny D, Hijazi ZM, Kar S, et al., Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position. J Am Coll Cardiol 2011; 58: 2248-2256.
23. Kenny D, Hijazi ZM,. Transcatheter pulmonary valve replacement: Current status and future potentials. Interv Cardiol Clin 2013; 2: 181-193.
24. Morray BH, McElhinney DB, Cheatham JP, et al., Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: A multicenter experience. Circ Cardiovasc Interven 2013; 6: 535-542.
25. McElhinney DB, Benson LN, Eicken A, Kreutzer J, Padera RF, Zahn EM,. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: Combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv 2013; 6: 292-300.